Vertex Pharmaceuticals Inc
SWB:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
|
W
|
Walmart Inc
XHAM:WMT
|
US |
|
A
|
Apple Inc
SGO:AAPL
|
US |
|
S
|
Sanofi SA
SWB:SNW
|
FR |
|
C
|
Capital One Financial Corp
XMUN:CFX
|
US |
|
S
|
Sands China Ltd
XBER:599A
|
MO |
|
W
|
Wharf Real Estate Investment Company Ltd
OTC:WRFRF
|
HK |
|
R
|
Ryde Group Ltd
AMEX:RYDE
|
SG |
|
C
|
China Resources Land Ltd
XMUN:CHZ
|
HK |
|
Boeing Co
LSE:0BOE
|
US |
|
C
|
Cisco Systems Inc
BMV:CSCO
|
US |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
S
|
Stericycle Inc
F:SY9
|
US |
|
B
|
Baidu Inc
F:B1C
|
CN |
|
HAL Trust
LSE:0K9V
|
MC |
|
Clemondo Group AB (publ)
F:N170
|
SE |
|
M
|
MHP Hotel AG
XMUN:CDZ0
|
DE |
|
Caltagirone SpA
F:QCG
|
IT |
|
S
|
Singapore Telecommunications Ltd
F:SIT4
|
SG |
|
W
|
Westinghouse Air Brake Technologies Corp
SWB:WB2
|
US |
|
C
|
Corning Inc
LSE:0R2X
|
US |
|
S
|
Smurfit Kappa Group PLC
DUS:SK3
|
IE |
|
A
|
Accenture PLC
XMUN:CSA
|
IE |
|
D
|
Duke Energy Corp
XHAM:D2MN
|
US |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 486.39 EUR with a low forecast of 289.04 EUR and a high forecast of 583.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
486.39
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 486.39 EUR with a low forecast of 289.04 EUR and a high forecast of 583.68 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
